ArticleMolecular therapy. Oncology2026

Enhancing cancer killing and natural killer cell persistence by targeting NOXA, a predictor of poor patient survival.

Sung-Bae Kang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.